Ventas, Inc. (VTR) Price CAGR:32.32%(TTM)
Over the latest trailing 12-month period, Ventas, Inc. (VTR)'s price cagr is +32.32%. The comparable SPY value is +21.37%. Year-to-date price return is +8.48%. Price CAGR uses adjusted close price history and excludes dividends.
Over longer horizons, Ventas, Inc.'s Price CAGR averages 22.37% over 3 years and 7.63% over 5 years. The price CAGR (Compound Annual Growth Rate) shows how Ventas, Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.
VTR Price CAGR Chart
Ventas, Inc. (VTR)
VTR Quarterly Price (YoY)
Price growth vs the same quarter one year earlier, last 20 quarters.
VTR Price CAGR History
| Year | Start Price | End Price | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | 49.85 | 63.15 | +13.30 | +26.68% | +26.68% |
| 2024 | 45.87 | 49.85 | +3.98 | +8.68% | +8.68% |
| 2023 | 49.94 | 45.87 | -4.07 | -8.15% | -8.15% |
| 2022 | 59.24 | 49.94 | -9.30 | -15.70% | -15.70% |
| 2021 | 35.46 | 59.24 | +23.78 | +67.06% | +67.06% |
| 2020 | 70.24 | 35.46 | -34.78 | -49.52% | -49.52% |
| 2019 | 55.05 | 70.24 | +15.19 | +27.59% | +27.59% |
| 2018 | 70.74 | 55.05 | -15.69 | -22.18% | -22.18% |
| 2017 | 69.88 | 70.74 | +0.86 | +1.23% | +1.23% |
| 2016 | 56.22 | 69.88 | +13.66 | +24.30% | +24.30% |
| 2015 | 56.61 | 56.22 | -0.39 | -0.69% | -0.69% |
| 2014 | 56.38 | 56.61 | +0.23 | +0.41% | +0.41% |
| 2013 | 53.46 | 56.38 | +2.92 | +5.46% | +5.46% |
| 2012 | 46.14 | 53.46 | +7.32 | +15.86% | +15.86% |
| 2011 | 43.39 | 46.14 | +2.75 | +6.34% | +6.34% |
| 2010 | 24.63 | 43.39 | +18.76 | +76.17% | +76.17% |
| 2009 | 38.04 | 24.63 | -13.41 | -35.25% | -35.25% |
| 2008 | 33.02 | 38.04 | +5.02 | +15.20% | +15.20% |
| 2007 | 28.27 | 33.02 | +4.75 | +16.80% | +16.80% |
| 2006 | 25.39 | 28.27 | +2.88 | +11.34% | +11.34% |
| 2005 | 20.42 | 25.39 | +4.97 | +24.34% | +24.34% |
| 2004 | 12.93 | 20.42 | +7.49 | +57.93% | +57.93% |
| 2003 | 11.59 | 12.93 | +1.34 | +11.56% | +11.56% |
| 2002 | 8.35 | 11.59 | +3.24 | +38.80% | +38.80% |
| 2001 | 3.34 | 8.35 | +5.01 | +150.00% | +150.00% |
| 2000 | 4.98 | 3.34 | -1.64 | -32.93% | -32.93% |
| 1999 | 12.92 | 4.98 | -7.94 | -61.46% | -61.46% |
| 1998 | 23.47 | 12.92 | -10.55 | -44.95% | -44.95% |
| 1997 | 17.35 | 23.47 | +6.12 | +35.27% | +35.27% |
Quarterly Price: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 84 | +2.8% | +32.4% |
| Q1 2026 | 82 | +2.5% | +22.1% |
| Q4 2025 | 80 | +16.3% | +35.2% |
| Q3 2025 | 68 | +8.1% | +7.3% |
| Q2 2025 | 63 | -5.2% | +27.1% |
| Q1 2025 | 67 | +13.5% | +56.7% |
| Q4 2024 | 59 | -7.7% | +21.6% |
| Q3 2024 | 64 | +28.0% | +45.1% |
| Q2 2024 | 50 | +16.9% | +5.5% |
| Q1 2024 | 43 | -11.9% | -3.0% |
| Q4 2023 | 48 | +10.1% | +6.4% |
| Q3 2023 | 44 | -7.0% | +1.3% |
| Q2 2023 | 47 | +7.5% | -5.3% |
| Q1 2023 | 44 | -3.3% | -27.0% |
| Q4 2022 | 45 | +4.7% | -11.4% |
| Q3 2022 | 43 | -13.0% | -23.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Ventas, Inc.
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Debra A. Cafaro